Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash $ 2,738 $ 15,563
Other Receivable 200
Total current assets: 2,938 15,563
Total assets 2,938 15,563
Current liabilities:    
Accounts payable 397,591 206,303
Accrued interest payable 20,742 8,413
Note payable, net of debt discount of $1,517 and $7,333, respectively 135,483 76,167
Note payable - related parties 16,000 6,000
Convertible note payable, net of debt discount of $0 and $9,333, respectively 121,000 111,667
Fair value of derivative liability - beneficial conversion feature 33,652 107,690
Deferred license income 85,481 60,491
Total current liabilities 809,949 576,731
Total liabilities 809,949 576,731
Stockholders' deficit:    
Preferred stock authorized 25,000,000 shares, $.0001 par value, no shares issued and outstanding at September 30, 2016 and December 31, 2015.
Common stock authorized 100,000,000 shares, $.0001 par value, 51,411,443 and 50,411,443 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively. 5,141 5,041
Additional paid-in capital 4,166,177 4,069,826
Accumulated deficit (4,978,329) (4,636,035)
Total stockholders' deficit (807,011) (561,168)
Total liabilities and stockholders' deficit $ 2,938 $ 15,563